Information Sheet: Ensuring the Quality and Safety of Plasma Derived Medicinal Products

Overview

This information sheet is intended to provide advise to National Medicine Regulatory Authorities, blood transfusion services, policy makers in national health authorities, manufacturers of plasma derived medicinal products and interested parties on the fundamental aspects supporting the quality and safety of these products.

WHO Team
Health Product Policy and Standards (HPS)
Number of pages
4